注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
Cognition Therapeutics Inc是一家临床阶段的生物制药公司。该公司主要发现和开发针对年龄相关的退行性疾病以及中枢神经系统(CNS)和视网膜疾病的小分子疗法。它正在开发一系列针对sigma-2受体(S2R)复合物小分子候选产品。这是一种调节疾病的细胞损伤反应的调节剂,例如阿尔茨海默病(AD)和干性年龄相关性黄斑变性(AMD)、地图样萎缩(GA)等情况。其主要候选产品CT1812是一种口服小分子拮抗剂,旨在穿透血脑屏障并选择性地与S2R复合物结合,并通过其调节恢复突触的正常功能,以及作用于关键细胞过程,如自噬、胆固醇生物合成、囊泡运输、孕酮信号传导和细胞表面受体稳定。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Susan Catalano | 59 | 2007 | Member of Scientific Advisory Board |
John Cirrito | - | - | Member of Scientific Advisory Board |
Michael Grundman | - | 2022 | Member of Medical Advisory Board |
Cynthia A. Lemere | - | - | Member of Scientific Advisory Board |
Harry LeVine | - | - | Member of Scientific Advisory Board |
Alison M. Goate | - | - | Member of Scientific Advisory Board |
Steven T. DeKosky | - | - | Member of Medical Advisory Board |
Jack A. Khattar | 63 | 2020 | Independent Chairman of the Board |
Robert H. Mach | - | - | Member of Scientific Advisory Board |
Tara L. Spires-Jones | - | - | Member of Scientific Advisory Board |
Aaron Glenn Louis Fletcher | 43 | 2015 | Independent Director |
Kaj Blennow | - | 2018 | Member of Medical Advisory Board |
Lisa Ricciardi | 64 | 2019 | CEO, President & Director |
Peggy Wallace | 67 | 2016 | Independent Director |
John Harrison | - | 2018 | Member of Medical Advisory Board |
Larry Ereshefsky | - | - | Member of Medical Advisory Board |
Brett P. Monia | 63 | 2020 | Independent Director |
Quang X. Pham | 59 | 2023 | Director |
Henrik Zetterberg | - | 2018 | Member of Medical Advisory Board |
Rolf Craven | - | - | Member of Scientific Advisory Board |
Philip Scheltens | - | - | Member of Medical Advisory Board |
Ellen B. Richstone | 72 | 2021 | Independent Director |
Mary Sano | - | - | Member of Medical Advisory Board |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核